Tsfg, LLC Abb Vie Inc. Transaction History

Tsfg, LLC

$458 Million
Q3 2024

A detailed history of Tsfg, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tsfg, LLC holds 104,688 shares of ABBV stock, worth $18.8 Million. This represents 4.51% of its overall portfolio holdings.

Number of Shares

104,688

Previous 106,320 1.53%

Holding current value

$18.8 Million

Previous $18.2 Million 13.37%

% of portfolio

4.51%

Previous 4.26%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $267,386 - $325,306	-1,632 Reduced 1.53%	104,688 $20.7 Million
Q2 2024 Jul 16, 2024	SELL	$154.79 - $180.76 $27,397 - $31,994	-177 Reduced 0.17%	106,320 $18.2 Million
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $3.02 Million - $3.45 Million	-18,924 Reduced 15.09%	106,497 $19.4 Million
Q4 2023 Jan 23, 2024	SELL	$137.6 - $154.97 $350,054 - $394,243	-2,544 Reduced 1.99%	125,421 $19.4 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $444,053 - $514,056	3,324 Added 2.67%	127,965 $19.1 Million
Q2 2023 Jul 10, 2023	BUY	$132.51 - $164.9 $123,499 - $153,686	932 Added 0.75%	124,641 $16.8 Million
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $243,234 - $280,120	-1,682 Reduced 1.34%	123,709 $19.7 Million
Q4 2022 Jan 19, 2023	BUY	$138.31 - $165.87 $645,907 - $774,612	4,670 Added 3.87%	125,391 $20.3 Million
Q3 2022 Oct 20, 2022	BUY	$134.21 - $153.93 $845,254 - $969,451	6,298 Added 5.5%	120,721 $16.2 Million
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $671,860 - $854,154	-4,882 Reduced 4.09%	114,423 $17.5 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $358,457 - $444,745	-2,716 Reduced 2.23%	119,305 $19.3 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $1.28 Million - $1.63 Million	11,958 Added 10.86%	122,021 $16.5 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $685,854 - $778,547	6,446 Added 6.22%	110,063 $11.9 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $318,049 - $354,325	3,023 Added 3.01%	103,617 $11.7 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $326,234 - $359,145	3,189 Added 3.27%	100,594 $10.9 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $123,793 - $167,134	-1,538 Reduced 1.55%	97,405 $10.4 Million
Q3 2020 Oct 06, 2020	BUY	$85.91 - $100.83 $1.16 Million - $1.36 Million	13,478 Added 15.77%	98,943 $8.67 Million
Q2 2020 Jul 07, 2020	BUY	$73.37 - $98.18 $876,478 - $1.17 Million	11,946 Added 16.25%	85,465 $8.39 Million
Q1 2020 Apr 08, 2020	SELL	$64.5 - $97.79 $11,158 - $16,917	-173 Reduced 0.23%	73,519 $5.6 Million
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $629,767 - $787,972	8,731 Added 13.44%	73,692 $6.53 Million
Q3 2019 Jan 27, 2020	BUY	$62.98 - $75.72 $797,263 - $958,539	12,659 Added 24.2%	64,961 $4.92 Million
Q2 2019 Jan 27, 2020	BUY	$65.7 - $83.98 $871,707 - $1.11 Million	13,268 Added 33.99%	52,302 $3.8 Million
Q1 2019 Jan 27, 2020	BUY	$77.14 - $90.79 $3.01 Million - $3.54 Million	39,034 New	39,034 $3.15 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.

Account